PowerShares Dynamic Biotechnology & Genome Portfolio (NYSEArca: PBE)
January Gain: 14.6%
Comment: PBE is one of the smart beta spins on biotech ETFs as the fund’s 30 holdings are selected on factors including price momentum, earnings momentum, quality, management action, and value. Only two stocks account for more than 5% of the ETF’s weight.